JPRN-jRCT1080222454未知Unknown
Rozerem 8 mg Tablets specified drug-use survey: <Long-term survey on associated with sleep-onset difficulty > - Transitional survey from the preceding drug-use survey
TAKEDA PHARMACEUTICAL COMPANY LTD.0 个研究点目标入组 100 人开始时间: 2014年4月7日最近更新:
适应症
试验速览
- 阶段
- Unknown
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- •Patients with difficulty falling asleep associated with insomnia who have completed a 4-week follow-up in the preceding drug use surveillance and are able to receive continuous administration of Rozerem Tablets
排除标准
- •Patients with contraindications to Rozerem Tablets
- •[1] Patients with previous history of hypersensitivity to ingredients in Rozerem Tablets
- •[2] Patients with severe liver dysfunction
- •[3] Patients taking fluvoxamine maleate
研究者
相似试验
未知
Unknown
Rozerem Tablets 8mg drug use surveillance: Survey on insomnia associated with sleep-onset difficultyInsomniaJPRN-jRCT1080222309TAKEDA PHARMACEUTICAL COMPANY LTD.3,000
已完成
不适用
Ramelteon 8 mg Tablets Specified Drug-use Survey: <Long-term Survey on Insomnia Accompanied by Difficulty Falling Asleep> - Transitional Survey From the Preceding Drug-use Survey -InsomniaNCT02153086Takeda236
已完成
不适用
Ramelteon Tablets 8mg Drug Use Surveillance: Survey on Insomnia Associated With Sleep-onset DifficultyInsomniaNCT02058992Takeda3,339
未知
Unknown
Blopress Tablets specified drug-use survey Hypertension: Survey on patients with metabolic syndromeHypertensionJPRN-jRCT1080222516TAKEDA PHARMACEUTICAL COMPANY LTD.15,000
已完成
不适用
Drug Use-results survey for Reminyl 4mg/8mg/12mg Tablets, 4mg/8mg/12mg OD Tablets, 4mg/mL Oral SolutioMild to moderately severe dementia of the Alzheimer's typeJPRN-UMIN000015897Janssen Pharmaceutical K.K.1,900